VALERIE NAZAREK: Open Payments
NPI 1275936114 · WEST MIFFLIN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 51 payments from 8 companies in 2025. Trend: 2023 $1,608 · 2024 $821 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $172 |
| Teva Pharmaceuticals USA, Inc. | 10 | $172 |
| ABBVIE INC. | 12 | $166 |
| Neurocrine BioSciences, Inc. | 10 | $156 |
| E.R. Squibb & Sons, L.L.C. | 4 | $83 |
| Janssen Pharmaceuticals, Inc | 4 | $71 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $16 |
Products named: VRAYLAR, INGREZZA, LYBALVI, UZEDY, COBENFY, INVEGA SUSTENNA, AUSTEDO XR, ARISTADA.
Industry payments across PA — which companies pay providers there.
